Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 4
2006 1
2007 1
2009 3
2010 7
2011 4
2013 5
2014 6
2015 6
2016 7
2017 4
2018 6
2019 5
2020 6
2021 1
2022 1
2023 2
2024 8
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.
Avallone A, Giuliani F, De Stefano A, Santabarbara G, Nasti G, Montesarchio V, Rosati G, Cassata A, Leo S, Romano C, Tamburini E, Silvestro L, Lotesoriere C, Nappi A, Santini D, Petrillo A, Colombo A, Febbraro A, Leone A, Mannavola F, Laterza MM, Izzo F, Sobrero A, Delrio P, Giannarelli D, Budillon A. Avallone A, et al. Among authors: febbraro a. J Clin Oncol. 2025 Mar;43(7):829-839. doi: 10.1200/JCO.24.00979. Epub 2024 Nov 22. J Clin Oncol. 2025. PMID: 39576946 Free PMC article. Clinical Trial.
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Cioli E, Latiano TP, De Stefano A, Tamburini E, Ramundo M, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Barruca V, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Normanno N, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: febbraro a. Eur J Cancer. 2025 Aug 26;226:115642. doi: 10.1016/j.ejca.2025.115642. Epub 2025 Jul 12. Eur J Cancer. 2025. PMID: 40669385 Clinical Trial.
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Latiano TP, De Stefano A, Tamburini E, Toma I, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Iacono D, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Cinieri S, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Cioli E, Normanno N, Di Maio M, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: febbraro a. ESMO Open. 2025 Apr;10(4):104511. doi: 10.1016/j.esmoop.2025.104511. Epub 2025 Mar 18. ESMO Open. 2025. PMID: 40107157 Free PMC article. Clinical Trial.
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.
Giordano G, Milella M, Landriscina M, Bergamo F, Tirino G, Santaniello A, Zaniboni A, Vasile E, De Vita F, Re GL, Vaccaro V, Giommoni E, Natale D, Conca R, Santini D, Maiorino L, Sanna G, Ricci V, Iop A, Montesarchio V, Procaccio L, Noventa S, Bianco R, Febbraro A, Lonardi S, Tortora G, Sperduti I, Melisi D. Giordano G, et al. Among authors: febbraro a. Cancer Med. 2024 Jun;13(12):e7345. doi: 10.1002/cam4.7345. Cancer Med. 2024. PMID: 38924262 Free PMC article.
76 results